VIENNA, Va., Oct. 23, 2017 /PRNewswire/ -- The Respiratory Compromise Institute (RCI) today announced it will present
Respiratory compromise is a deterioration of respiratory function that poses a high risk of life-threatening respiratory failure. Respiratory failure is the second leading avoidable patient safety issue.1 It is one of the top five conditions leading to increasing hospital costs2 and the third most rapidly increasing hospital inpatient cost in the United States.3 General care floor patients with respiratory compromise are 29 times more likely to die.2
The plenary workshop presentation, entitled "The Respiratory Compromise Institute and Its Current and Future Research Endeavors," is scheduled for Tuesday, October 31 at the Metro Toronto Convention Centre, South Building, Level 600, Room 603, from 7:30 a.m. - 8:30 a.m. ET. Presenters include: Gerry Criner, MD, FACP, FACCP, Chair and Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University; Phillip Porte, Executive Director of RCI; James Lamberti, MD, FCCP, Professor of Medicine, Virginia Commonwealth University School of Medicine, Inova Campus; Sidney Braman, MD, FCCP, Ichan School of Medicine at Mount Sinai; Neil MacIntyre, MD, FCCP, Duke University Hospital; and Jeffrey Vender, MD, FCCP, Evanston Hospital.
Workshop sub-sessions will include:
"Our institute's mission is to bring greater visibility and recognition to respiratory compromise — a serious, potentially life-threatening condition, associated with significant morbidity and increased hospital costs," said Mr. Porte. "Presenting at CHEST 2017 will enable us to further this mission, communicating how important it is that the medical community, including policymakers, healthcare experts and hospital systems, help develop effective intervention strategies to improve patient health by preventing and mitigating respiratory compromise."
Learn more about the Respiratory Compromise Institute by visiting: http://www.respiratorycompromise.org/
About Respiratory CompromiseRespiratory compromise, which includes respiratory distress, insufficiency, failure and arrest, can occur across numerous clinical scenarios. For example, respiratory compromise may appear post-operatively or may be drug-induced by the delivery of a sedative, opioid, or analgesic to patients who were not properly assessed or properly monitored.
According to the U.S. Department of Health & Human Services, Agency for Healthcare Research and Quality, respiratory compromise is the third most rapidly increasing hospital inpatient cost in the United States, with $7.8 billion spent on respiratory compromise in U.S. hospitals in 2007. Respiratory compromise increases patient mortality rates by over 30 percent and hospital and ICU stays by almost 50 percent. RCI defines respiratory compromise as a state in which there is a high likelihood of decompensation into respiratory insufficiency, respiratory failure or death that could be prevented or mitigated through specific interventions (enhanced monitoring and/or therapies).
About Respiratory Compromise Institute The Respiratory Compromise Institute brings together a broad-based coalition of organizations, companies, and individuals dedicated to reducing—and eventually eliminating—preventable adverse events and deaths due to respiratory compromise.
1 Healthgrades website, "Quality Matters: Tackle the Top 3 Patient Safety Issues." https://www.hospitals.healthgrades.com/index.cfm/customers/e-newsletters/april-2013/quality-matters-tackle-the-top-3-patient-safety-issues/. Accessed October 10, 2017.
2 Kelley SD, SA, Agarwal S, Parikh N, Erslon M, Morris P. Respiratory insufficiency, arrest and failure among medical patients on the general care floor. Crit Care Med. 2012; 40(12):764.
3 NAMDRC, National Association for Medical Direction of Respiratory Care. Reducing respiratory compromise and depression. PR Web. Available at http://www.prweb.com/pdfdownload/12615503.pdf.
Media Contact Erich Sandoval Lazar Partners Ltd. Tel: +1 917-497-2867Email: email@example.com
View original content:http://www.prnewswire.com/news-releases/respiratory-compromise-institute-selected-to-present-at-chest-2017-300541252.html
SOURCE Respiratory Compromise Institute
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All